Fig. 3From: Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trialsArm-specific distant-recurrence free survival in the illustrated breast cancer trial. Vertical lines: 95% confidence interval at 5Â yearsBack to article page